The new regulatory circuit of E2/ERα/miR-124/AKT2 in BC plays an important role in BC tumorigenesis and development, which will provide potential novel biomarkers and targets for the diagnosis and treatment of BC. This evidence concerns the gene ESR1 and breast cancer.